Webcast Alert: Derma Sciences, Inc. Announces the LHA Life Sciences & Med Tech Day 2010 Presentation

NEW YORK, July 14 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI) announces the following Webcast:

If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=160488 or http://www.investorcalendar.com/

Derma Sciences is a global medical device and pharmaceutical company focused on wound care.  Its MEDIHONEY® product is the leading brand of honey-based dressings for the management of wounds and burns.  The product has been shown to be effective in a variety of indications, and was the focus of a positive large-scale, randomized controlled trial involving 108 leg ulcer patients.  Other novel products introduced into the $14 billion global wound care market include XTRASORB® for better management of wound exudates, and BIOGUARD™ for infection prevention.  Derma Sciences also expects to complete preclinical studies with DSC127, a novel pharmaceutical for accelerated wound healing and scar reduction, by the end of 2010.  For more information please visit www.dermasciences.com.

SOURCE Derma Sciences, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED